Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](iqvia)"
Count: 121
Selected: 0
NCT IDTitle
NCT04368065COVID-19 Active Research Experience (CARE)
NCT04025307Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours
NCT05269316Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
NCT05218642To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
NCT05066698ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
NCT05037760Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in Myelofibrosis
NCT05030831Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE
NCT04907968Study of Upifitamab Rilsodotin in Combination With Other Agent(s) in Participants With High-grade Serous Ovarian Cancer
NCT04720378Safety and Tolerability Study of IV ST266 in COVID-19 Subjects
NCT04633278CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT04396340First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b
NCT04188574A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
NCT04167137Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects
NCT04123574A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
NCT04072835Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
NCT04053387Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)
NCT03983980Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
NCT03956355Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
NCT03628235HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States
NCT03466320DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
NCT02678572Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma
NCT05264506Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive
NCT05084508A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age
NCT05306574A Phase 3 Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus
NCT05286853A Study of Renal Autologous Cell Therapy (REACT®) in Participants With Type 2 Diabetes and Chronic Kidney Disease
NCT05243680An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)
NCT05189977A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
NCT05169307CPX-351 Real-World Effectiveness and Safety Study
NCT05101187Olorofim Aspergillus Infection Study
NCT05055921MultiPulse Therapy (MPT) for AF (US)
NCT05035680Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion
NCT04981795realMIND: Observational Study of Patients With Relapsed or Refractory DLBCL Starting Second- or Third-line Therapy
NCT04959799Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)
NCT04877691Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
NCT04818801Safety, Reactogenicity and Immunogenicity Study of ReCOV
NCT04814680Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate
NCT04744363Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)
NCT04719832Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04718389A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04718103A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04646889Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment
NCT04625972Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults
NCT04625725Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
NCT04620148TAK-242 in Patients With Acute Alcoholic Hepatitis
NCT04612725A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)
NCT04605094Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis
NCT04600752Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India
NCT04568031Study of AZD1222 for the Prevention of COVID-19 in Japan
NCT04542057A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
NCT04535986A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD